AGIO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Agios Pharmaceuticals Inc (AGIO).


$1.87B Market Cap.

As of 02/13/2025 5:00 PM ET (MRY) • Disclaimer

AGIO Market Cap. (MRY)


AGIO Shares Outstanding (MRY)


AGIO Assets (MRY)


Total Assets

$1.66B

Total Liabilities

$122.24M

Total Investments

$1.46B

AGIO Income (MRY)


Revenue

$36.50M

Net Income

$673.73M

Operating Expense

-$431.07M

AGIO Cash Flow (MRY)


CF Operations

-$389.84M

CF Investing

$363.44M

CF Financing

$14.44M

AGIO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AGIO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,663,199,000 (77.48%)

$937,118,000 (-24.35%)

$1,238,718,000 (-13.84%)

$1,437,736,000 (68.56%)

Assets Current

$965,600,000 (15.80%)

$833,835,000 (0.13%)

$832,772,000 (-21.75%)

$1,064,231,000 (67.15%)

Assets Non-Current

$697,599,000 (575.42%)

$103,283,000 (-74.56%)

$405,946,000 (8.69%)

$373,505,000 (72.70%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$1,540,956,000 (90.00%)

$811,019,000 (-26.33%)

$1,100,814,000 (-14.80%)

$1,291,975,000 (223.40%)

Property Plant & Equipment Net

$54,554,000 (-21.83%)

$69,791,000 (-20.80%)

$88,116,000 (-15.46%)

$104,230,000 (-10.20%)

Cash & Equivalents

$76,247,000 (-13.56%)

$88,205,000 (-36.66%)

$139,259,000 (-31.44%)

$203,126,000 (59.39%)

Accumulated Other Comprehensive Income

-$1,518,000 (-244.22%)

-$441,000 (96.48%)

-$12,535,000 (-946.33%)

-$1,198,000 (-1240.95%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$1,455,784,000 (102.71%)

$718,158,000 (-25.01%)

$957,734,000 (-11.59%)

$1,083,267,000 (99.46%)

Investments Current

$817,463,000 (18.69%)

$688,723,000 (6.97%)

$643,860,000 (-21.18%)

$816,892,000 (83.37%)

Investments Non-Current

$638,321,000 (2068.58%)

$29,435,000 (-90.62%)

$313,874,000 (17.83%)

$266,375,000 (172.90%)

Inventory

$27,616,000 (44.77%)

$19,076,000 (124.63%)

$8,492,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$4,109,000 (46.23%)

$2,810,000 (27.38%)

$2,206,000 (-49.61%)

$4,378,000 (0%)

Trade & Non-Trade Payables

$16,643,000 (70.17%)

$9,780,000 (-47.46%)

$18,616,000 (11.47%)

$16,700,000 (-5.78%)

Accumulated Retained Earnings (Deficit)

-$148,924,000 (81.90%)

-$822,649,000 (-74.82%)

-$470,561,000 (-97.09%)

-$238,760,000 (87.05%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$871,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$56,988,000 (-20.85%)

$71,996,000 (-15.95%)

$85,659,000 (-11.78%)

$97,094,000 (-7.70%)

Debt Current

$16,781,000 (11.81%)

$15,008,000 (9.84%)

$13,663,000 (22.44%)

$11,159,000 (50.59%)

Debt Non-Current

$40,207,000 (-29.45%)

$56,988,000 (-20.85%)

$71,996,000 (-16.22%)

$85,935,000 (-12.12%)

Total Liabilities

$122,243,000 (-3.06%)

$126,099,000 (-8.56%)

$137,904,000 (-5.39%)

$145,761,000 (-67.86%)

Liabilities Current

$81,156,000 (19.43%)

$67,955,000 (8.50%)

$62,629,000 (4.69%)

$59,826,000 (-36.62%)

Liabilities Non-Current

$41,087,000 (-29.34%)

$58,144,000 (-22.76%)

$75,275,000 (-12.40%)

$85,935,000 (-76.07%)

AGIO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$36,498,000 (36.07%)

$26,823,000 (88.36%)

$14,240,000 (0%)

$0 (0%)

Cost of Revenue

$4,165,000 (44.57%)

$2,881,000 (69.07%)

$1,704,000 (0%)

$0 (0%)

Selling General & Administrative Expense

$156,784,000 (30.76%)

$119,903,000 (-1.45%)

$121,673,000 (0.19%)

$121,445,000 (5.51%)

Research & Development Expense

$301,286,000 (1.95%)

$295,526,000 (5.58%)

$279,910,000 (8.93%)

$256,973,000 (16.38%)

Operating Expenses

-$431,066,000 (-203.76%)

$415,429,000 (57.43%)

$263,879,000 (-29.02%)

$371,779,000 (10.68%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$44,244,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

-$1,961,225,000 (-101255.30%)

Consolidated Income

$673,725,000 (291.35%)

-$352,088,000 (-51.89%)

-$231,801,000 (-114.44%)

$1,604,715,000 (590.18%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$673,725,000 (291.35%)

-$352,088,000 (-51.89%)

-$231,801,000 (-114.44%)

$1,604,715,000 (590.18%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$673,725,000 (291.35%)

-$352,088,000 (-51.89%)

-$231,801,000 (-114.44%)

$1,604,715,000 (590.18%)

Weighted Average Shares

$56,807,415 (2.08%)

$55,651,487 (1.57%)

$54,789,435 (-9.36%)

$60,447,346 (-12.39%)

Weighted Average Shares Diluted

$57,889,255 (4.02%)

$55,651,487 (1.57%)

$54,789,435 (-9.36%)

$60,447,346 (-12.39%)

Earning Before Interest & Taxes (EBIT)

$717,969,000 (303.92%)

-$352,088,000 (-51.89%)

-$231,801,000 (-114.44%)

$1,604,715,000 (590.18%)

Gross Profit

$32,333,000 (35.05%)

$23,942,000 (90.99%)

$12,536,000 (0%)

$0 (0%)

Operating Income

$463,399,000 (218.37%)

-$391,487,000 (-55.76%)

-$251,343,000 (32.39%)

-$371,779,000 (-10.68%)

AGIO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$363,441,000 (51.70%)

$239,575,000 (-1.52%)

$243,261,000 (143.90%)

-$554,158,000 (-823.93%)

Net Cash Flow from Financing

$14,442,000 (165.82%)

$5,433,000 (15.60%)

$4,700,000 (100.31%)

-$1,531,536,000 (-662.03%)

Net Cash Flow from Operations

-$389,841,000 (-31.68%)

-$296,062,000 (4.34%)

-$309,478,000 (1.47%)

-$314,086,000 (-28.75%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,958,000 (76.58%)

-$51,054,000 (20.06%)

-$63,867,000 (-184.38%)

$75,690,000 (62.76%)

Net Cash Flow - Business Acquisitions and Disposals

$1,089,136,000 (0%)

$0 (0%)

$131,784,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$724,050,000 (-382.01%)

$256,749,000 (122.50%)

$115,394,000 (121.04%)

-$548,417,000 (-704.95%)

Capital Expenditure

-$1,645,000 (-604.60%)

$326,000 (108.32%)

-$3,917,000 (31.77%)

-$5,741,000 (59.30%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$331,000 (42.73%)

-$578,000 (-72.02%)

Issuance (Purchase) of Equity Shares

$14,442,000 (165.82%)

$5,433,000 (102.65%)

$2,681,000 (100.35%)

-$765,190,000 (-6861.42%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$42,847,000 (-4.29%)

$44,766,000 (-9.19%)

$49,296,000 (-7.87%)

$53,508,000 (-13.14%)

Depreciation Amortization & Accretion

$17,183,000 (-0.92%)

$17,343,000 (-6.55%)

$18,559,000 (-1.16%)

$18,777,000 (0.03%)

AGIO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

88.60% (-0.78%)

89.30% (1.48%)

88.00%

-

Profit Margin

1845.90% (240.63%)

-1312.60% (19.36%)

-1627.80%

-

EBITDA Margin

2014.20% (261.39%)

-1248.00% (16.66%)

-1497.50%

-

Return on Average Equity (ROAE)

58.90% (254.59%)

-38.10% (-84.06%)

-20.70% (-121.63%)

95.70% (250.71%)

Return on Average Assets (ROAA)

53.10% (257.57%)

-33.70% (-82.16%)

-18.50% (-121.17%)

87.40% (336.22%)

Return on Sales (ROS)

1967.10% (249.86%)

-1312.60% (19.36%)

-1627.80%

-

Return on Invested Capital (ROIC)

64.10% (278.55%)

-35.90% (-83.16%)

-19.60% (-112.24%)

160.10% (536.24%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

2.77 (178.77%)

-3.52 (47.00%)

-6.64 (-636.19%)

1.24 (113.54%)

Price to Sales Ratio (P/S)

51.15 (10.69%)

46.2 (-57.23%)

108.04

-

Price to Book Ratio (P/B)

1.22 (-20.78%)

1.53 (9.49%)

1.4 (1.45%)

1.38 (-81.60%)

Debt to Equity Ratio (D/E)

0.08 (-49.03%)

0.15 (24.00%)

0.13 (10.62%)

0.11 (-90.04%)

Earnings Per Share (EPS)

11.86 (287.36%)

-6.33 (-49.65%)

-4.23 (-115.93%)

26.55 (660.13%)

Sales Per Share (SPS)

0.64 (33.20%)

0.48 (85.38%)

0.26 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-6.89 (-29.68%)

-5.31 (7.10%)

-5.72 (-8.11%)

-5.29 (-41.47%)

Book Value Per Share (BVPS)

27.13 (86.14%)

14.57 (-27.47%)

20.09 (-6.00%)

21.37 (269.15%)

Tangible Assets Book Value Per Share (TABVPS)

29.28 (73.87%)

16.84 (-25.52%)

22.61 (-4.94%)

23.79 (92.40%)

Enterprise Value Over EBIT (EV/EBIT)

2 (150.00%)

-4 (42.86%)

-7 (-800.00%)

1 (110.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

2.29 (160.95%)

-3.75 (46.99%)

-7.08 (-874.40%)

0.91 (108.65%)

Asset Turnover

0.03 (11.54%)

0.03 (136.36%)

0.01 (0%)

0 (0%)

Current Ratio

11.9 (-3.03%)

12.27 (-7.72%)

13.3 (-25.25%)

17.79 (163.74%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$391,486,000 (-32.38%)

-$295,736,000 (5.63%)

-$313,395,000 (2.01%)

-$319,827,000 (-23.94%)

Enterprise Value (EV)

$1,681,116,208 (33.86%)

$1,255,863,895 (-16.79%)

$1,509,326,556 (1.70%)

$1,484,030,540 (-54.50%)

Earnings Before Tax (EBT)

$717,969,000 (303.92%)

-$352,088,000 (-51.89%)

-$231,801,000 (-114.44%)

$1,604,715,000 (590.18%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$735,152,000 (319.62%)

-$334,745,000 (-56.98%)

-$213,242,000 (-113.13%)

$1,623,492,000 (626.09%)

Invested Capital

$1,562,784,000 (83.22%)

$852,954,000 (-24.01%)

$1,122,489,000 (-11.75%)

$1,271,878,000 (72.73%)

Working Capital

$884,444,000 (15.48%)

$765,880,000 (-0.55%)

$770,143,000 (-23.32%)

$1,004,405,000 (85.22%)

Tangible Asset Value

$1,663,199,000 (77.48%)

$937,118,000 (-24.35%)

$1,238,718,000 (-13.84%)

$1,437,736,000 (68.56%)

Market Capitalization

$1,874,012,208 (50.56%)

$1,244,698,895 (-19.32%)

$1,542,851,556 (-13.57%)

$1,785,119,540 (-40.52%)

Average Equity

$1,143,015,000 (23.62%)

$924,656,000 (-17.49%)

$1,120,626,750 (-33.15%)

$1,676,295,750 (224.91%)

Average Assets

$1,269,441,250 (21.45%)

$1,045,206,750 (-16.51%)

$1,251,841,000 (-31.80%)

$1,835,567,750 (107.57%)

Invested Capital Average

$1,120,090,000 (14.25%)

$980,385,250 (-17.04%)

$1,181,758,500 (17.92%)

$1,002,161,000 (12.48%)

Shares

57,030,195 (2.04%)

55,891,284 (1.72%)

54,944,856 (1.17%)

54,308,474 (-21.59%)